VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.
Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN. Blood. 2017 09 28; 130(13):1514-1522.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic
Azacitidine
Blood Transfusion
Cytogenetic Analysis
Disease-Free Survival
Humans
Leukemia, Myelomonocytic, Chronic
Middle Aged
Myelodysplastic Syndromes
Myelodysplastic-Myeloproliferative Diseases
Neoplasms
Risk
Survival Rate
authors with profiles
CARLOS E BUESO-RAMOS
ZEEV ESTROV
GUILLERMO GARCIA-MANERO
YESID ALVARADO
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
TAPAN MAHENDRA KADIA
NAVEEN PEMMARAJU
HAGOP M KANTARJIAN